Jim Simons Novo Cure LTD Transaction History
Renaissance Technologies LLC
- $63.6 Billion
- Q1 2024
A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Novo Cure LTD stock. As of the latest transaction made, Renaissance Technologies LLC holds 279,575 shares of NVCR stock, worth $5.04 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
279,575
Previous 101,375
175.78%
Holding current value
$5.04 Million
Previous $1.51 Million
188.64%
% of portfolio
0.01%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding NVCR
# of Institutions
277Shares Held
73.2MCall Options Held
1.43MPut Options Held
832K-
Vanguard Group Inc Valley Forge, PA10MShares$181 Million0.0% of portfolio
-
Black Rock Inc. New York, NY9.08MShares$164 Million0.0% of portfolio
-
Capital International Investors Los Angeles, CA8.86MShares$160 Million0.03% of portfolio
-
State Street Corp Boston, MA3.36MShares$60.7 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.38MShares$42.9 Million0.0% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $1.89B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...